Biosceptre's Phase 1 Clinical Trial for anti-cancer antibody BIL03s approved by Ethics Committee - PR News

Press Release Distribution Service

Latest News from PR Log

Agriculture - Latest News

Automotive - Latest News

Biotech - Latest News

Computers - Latest News

Deals - Latest News

Defense - Latest News

Education - Latest News

Thursday, 16 March 2017

Biosceptre's Phase 1 Clinical Trial for anti-cancer antibody BIL03s approved by Ethics Committee

Biosceptre's proposed Phase I clinical trial for BIL03s (anti-cancer monoclonal antibody therapy) was granted conditional approval by the Bellberry Ethics committee.

No comments:

Post a Comment

Electronics - Latest News